| |
| |
|
| Insider
Information: |
Lizzul Paul F. |
| Relationship: |
Chief Medical Officer |
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
206,606 |
|
|
Indirect Shares
|
10,557 |
|
|
| Direct
Value |
$263,271 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
217,163 |
|
|
| Total
Value |
$263,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -20.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sienna Biopharmaceuticals, Inc. |
SNNA |
|
2019-08-06 |
196,488 |
2019-08-06 |
10,557 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
Chief Medical Officer |
2024-01-08 |
10,118 |
2021-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANAB |
Anaptysbio Inc |
Chief Medical Officer |
• – – |
2024-01-08 |
4 |
S |
$21.81 |
$55,703 |
D/D |
(2,554) |
10,118 |
0 |
% |
|
| ANAB |
Anaptysbio Inc |
Chief Medical Officer |
• – – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,145 |
12,672 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Chief Medical Officer |
• – – |
2023-09-14 |
4 |
S |
$19.48 |
$41,005 |
D/D |
(2,105) |
6,527 |
0 |
% |
|
| ANAB |
Anaptysbio Inc |
Chief Medical Officer |
• – – |
2023-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
8,632 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Chief Medical Officer |
• – – |
2021-11-15 |
4 |
A |
$22.03 |
$21,237 |
D/D |
964 |
964 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Medical Officer |
• – – |
2019-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
196,488 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Medical Officer |
• – – |
2019-07-02 |
4 |
D |
$0.76 |
$3,112 |
D/D |
(4,095) |
141,488 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Medical Officer |
• – – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
142,583 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Medical Officer |
• – – |
2017-08-01 |
4 |
B |
$15.00 |
$150,000 |
D/D |
10,000 |
94,634 |
2.74 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Medical Officer |
• – – |
2017-08-01 |
4 |
A |
$0.00 |
$0 |
I/I |
10,557 |
10,557 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Medical OfficerOfficer |
• – – |
2017-07-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
84,634 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
